Back to Search
Start Over
AiViva Biopharma completes patient enrollment in phase 1 trial of AIV007 for age-related macular degeneration and diabetic macular edema
- Source :
- PharmaBiz. August 26, 2024
- Publication Year :
- 2024
-
Abstract
- AiViva Biopharma Inc., a clinical-stage biotechnology company, announced that it has fully enrolled and completed dosing the last patient in a phase 1 trial with wet age-related macular degeneration (wAMD), [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- PharmaBiz
- Publication Type :
- Periodical
- Accession number :
- edsgcl.806087402